JMP Securities Initiates SteadyMed With Market Outperform

by Monica Gerson, Benzinga Staff Writer
April 14, 2015 9:29 AM | 11 seconds read |
Analysts at JMP Securities initiated coverage on SteadyMed Ltd. STDY with a Market Outperform rating. The target price for SteadyMed is set to $20. SteadyMed shares closed at $8.65 yesterday.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: InitiationAnalyst RatingsJMP Securities
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!